» Articles » PMID: 34301443

Development of Whole-body Representation and Dose Calculation in a Commercial Treatment Planning System

Overview
Journal Z Med Phys
Specialty Radiology
Date 2021 Jul 24
PMID 34301443
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

For the epidemiological evaluation of long-term side effects of radiotherapy patients, it is important to know the doses to organs and tissues everywhere in the patient. Computed tomography (CT) images of the patients which contain the anatomical information are sometimes available for each treated patient. However, the available CT scans usually cover only the treated volume of the patient including the target and surrounding anatomy. To overcome this limitation, in this work we describe the development of a software tool using the Varian Eclipse Scripting API for extending a partial-body CT to a whole-body representation in the treatment planning system for dose calculation. The whole-body representation is created by fusing the partial-body CT with a similarly sized whole-body computational phantom selected from a library containing 64 phantoms of different heights, weights, and genders. The out-of-field dose is calculated with analytical models from the literature and merged with the treatment planning system-calculated dose. To test the method, the out-of-field dose distributions on the computational phantoms were compared to dose calculations on whole-body patient CTs. The mean doses, D2% and D98% were compared in 26 organs and tissues for 14 different treatment plans in 5 patients using 3D-CRT, IMRT, VMAT, coplanar and non-coplanar techniques. From these comparisons we found that mean relative differences between organ doses ranged from -10% and +20% with standard deviations of up to 40%. The developed method will help epidemiologists and researchers estimate organ doses outside the treated volume when only limited treatment planning CT information is available.

Citing Articles

Experimental Validation of an Analytical Program and a Monte Carlo Simulation for the Computation of the Far Out-of-Field Dose in External Beam Photon Therapy Applied to Pediatric Patients.

De Saint-Hubert M, Suesselbeck F, Vasi F, Stuckmann F, Rodriguez M, Dabin J Front Oncol. 2022; 12:882506.

PMID: 35875147 PMC: 9300838. DOI: 10.3389/fonc.2022.882506.

References
1.
Hauri P, Schneider U . Whole-body dose equivalent including neutrons is similar for 6 MV and 15 MV IMRT, VMAT, and 3D conformal radiotherapy. J Appl Clin Med Phys. 2019; 20(3):56-70. PMC: 6414138. DOI: 10.1002/acm2.12543. View

2.
Miller K, Siegel R, Lin C, Mariotto A, Kramer J, Rowland J . Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016; 66(4):271-89. DOI: 10.3322/caac.21349. View

3.
Newhauser W, Schneider C, Wilson L, Shrestha S, Donahue W . A REVIEW OF ANALYTICAL MODELS OF STRAY RADIATION EXPOSURES FROM PHOTON- AND PROTON-BEAM RADIOTHERAPIES. Radiat Prot Dosimetry. 2017; 180(1-4):245-251. DOI: 10.1093/rpd/ncx245. View

4.
Schneider C, Newhauser W, Wilson L, Schneider U, Kaderka R, Miljanic S . A descriptive and broadly applicable model of therapeutic and stray absorbed dose from 6 to 25 MV photon beams. Med Phys. 2017; 44(7):3805-3814. DOI: 10.1002/mp.12286. View

5.
Xu X . An exponential growth of computational phantom research in radiation protection, imaging, and radiotherapy: a review of the fifty-year history. Phys Med Biol. 2014; 59(18):R233-302. PMC: 4169876. DOI: 10.1088/0031-9155/59/18/R233. View